# US 2024/0254423 A1 · Cell capture device, cell capture apparatus, and cell capture method

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0254423 A1
- Document ID: US20240254423A1
- Status: Published application
- Kind: A1
- Application number: 18/561,495
- Filed: 2022-06-28
- Published: 2024-08-01
- Earliest claimed: 2021-07-28
- Assignees: Phc Holdings Corporation
- Applicants: PHC Holdings Corporation
- Inventors: Akira NISHIO; Fumiya MATSUBARA; Yasushi TANIMOTO; Masahiro JOHNO
- Web page: https://patentgrep.com/patent/US20240254423A1

## CPC

- C12M 33/10: {by centrifugation (centrifuges in general B04B); Cyclones (cyclones in general B04C)}
- C12N 1/02: Separating microorganisms from their culture media
- C12M 23/06: {Tubular (C12M23/08, C12M23/16 take precedence)}
- C12M 23/20: {Material Coatings (immunocoatings C12M25/00)}
- C12M 47/04: {Cell isolation or sorting (purging biological preparations of unwanted cells C12N5/0081, determining the presence or kind of microorganism C12Q1/04)}
- C12M: APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; {APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

A cell capture apparatus comprises a centrifugal container that can be mounted in a centrifuge, and that has a space in which a test liquid containing target cells is held, and an inner surface that defines the space; and a cell adhesion layer that is disposed on the inner surface and adsorbs the target cells in the test liquid.

## Claims

### Claim 1

A cell capture device, comprising:
a centrifugal container that can be mounted in a centrifuge, and that has a space in which a test liquid containing target cells is held, and an inner surface that defines the space; and
a cell adhesion layer that is disposed on the inner surface and is configured to adsorb the target cells in the test liquid.

### Claim 2 (depends on 1)

The cell capture device according to claim 1, wherein the cell adhesion layer is disposed in a capture region of the inner surface that is not parallel to a centrifugal direction of the centrifugal container.

### Claim 3 (depends on 2)

The cell capture device according to claim 2, further comprising a cell adhesion suppression layer that is disposed in a region of the inner surface other than the capture region, and that is configured to suppress adsorption of the target cells in the test liquid.

### Claim 4 (depends on 1)

The cell capture device according to claim 1, wherein the target cells include at least one type selected from a group consisting of circulating tumor cells, stem cells, vascular endothelial cells, nerve cells, dendritic cells, smooth muscle cells, fibroblasts, cardiomyocytes, skeletal muscle cells, hepatic parenchymal cells, hepatic stellate cells, and pancreatic islet cells, and the cell adhesion layer adsorbs the target cells.

### Claim 5 (depends on 1)

The cell capture device according to claim 1, wherein the cell adhesion layer includes a first biocompatible polymeric material, and
the first biocompatible polymeric material includes one or more of polymers expressed by the following formulas 1 to 4, or a copolymer of a monomer constituting the polymer expressed by formula 1 and a monomer constituting one or more types of polymer selected from a group consisting of polyethylene glycol, polyvinyl pyrrolidone, polyvinyl methyl ether, polymethoxyethyl acrylamide, polymethoxyethyl methacrylamide, polymethoxyethyl vinyl ether, polytetrahydrofurfuryl acrylate, and polytetrahydrofurfuryl methacrylate.
(In formula 1, R1 is a hydrogen atom or a methyl group, R2 is a methyl group or an ethyl group, m is an integer of 1, 2, or 3, and n is a repeating unit.)
(In formula 2, R1 is a hydrogen atom or a methyl group, and n is a repeating unit.)
(In formula 3, X and Y are each independently a hydrogen atom, an alkali metal atom, or an ammonium group, m is an integer of 0, 1, or 2, and n is a repeating unit.)
(In formula 4, R1 is a hydrogen atom or an organic group having 1 to 30 carbon atoms, and n is a repeating unit.)

### Claim 6 (depends on 3)

The cell capture device according to claim 3, wherein the cell adhesion suppression layer includes a second biocompatible polymeric material, and
the second biocompatible polymeric material includes a polymer having phospholipid polar groups.

### Claim 7 (depends on 3)

The cell capture device according to claim 3, wherein the centrifugal container has a cylindrical shape having the space,
the space has a columnar shape,
the inner surface includes a side surface portion that defines a side portion of the columnar shape, and a bottom surface portion that defines a bottom portion of the columnar shape, and
the cell adhesion layer covers the bottom surface portion of a columnar inner surface.

### Claim 8 (depends on 7)

The cell capture device according to claim 7, wherein the bottom surface portion is partially spherical.

### Claim 9 (depends on 8)

The cell capture device according to claim 8, wherein the cell adhesion layer is disposed on an arc with respect to a center of rotation.

### Claim 10 (depends on 7)

The cell capture device according to claim 7, wherein the cell adhesion suppression layer covers the side surface portion of the columnar inner surface.

### Claim 11 (depends on 3)

The cell capture device according to claim 3, wherein the centrifugal container has a disk shape having an upper surface, a lower surface, and a rotary shaft,
the space is formed at a position that is away from the rotary shaft of the disk shape in a radial direction,
the inner surface includes an outer side surface portion that is farthest away from the rotary shaft in the radial direction, and
the cell adhesion layer is disposed on the outer side surface portion.

### Claim 12 (depends on 11)

The cell capture device according to claim 11, wherein the cell adhesion suppression layer covers a surface of the inner surface other than the outer side surface portion.

### Claim 13 (depends on 1)

A cell capture apparatus, comprising:
the cell capture device according to claim 1; and
a centrifuge in which the cell capture device can be mounted, and that is configured to apply centrifugal force to the cell capture device by rotating the cell capture device.

### Claim 14

A cell capture method, comprising following steps:
introducing a test liquid containing target cells into a space of a cell capture device comprising a space for holding a test liquid containing target cells, a centrifugal container having an inner surface that defines the space, and a cell adhesion layer including a first biocompatible polymeric material that is disposed on the inner surface and adsorbs the target cells in the test liquid; and
mounting the cell capture device in a centrifuge and rotating the cell capture device to adsorb the target cells to the cell adhesion layer.

### Claim 15 (depends on 14)

The cell capture method according to claim 14, wherein, in the step of adsorption, a centrifugal force of at least 500 G and no more than 10,000 G is applied to the test liquid held in the cell capture device.

### Claim 16 (depends on 14)

The cell capture method according to claim 14, further comprising a step of bringing a liquid containing water into contact with the cell adhesion layer prior to the step of introduction.

### Claim 17 (depends on 14)

The cell capture method according to claim 14, wherein the cell adhesion layer is disposed in a capture region of the inner surface that is not parallel to a centrifugal direction of the centrifugal container.

### Claim 18 (depends on 14)

The cell capture method according to claim 14, wherein the target cells include at least one type selected from a group consisting of circulating tumor cells, stem cells, vascular endothelial cells, nerve cells, dendritic cells, smooth muscle cells, fibroblasts, cardiomyocytes, skeletal muscle cells, hepatic parenchymal cells, hepatic stellate cells, and pancreatic islet cells, and the cell adhesion layer adsorbs the target cells.

### Claim 19 (depends on 14)

The cell capture method according to claim 14, wherein the first biocompatible polymeric material includes one or more of polymers expressed by the following formulas 1 to 4, or a copolymer of a monomer constituting the polymer expressed by formula 1 and a monomer constituting one or more types of polymer selected from a group consisting of polyethylene glycol, polyvinyl pyrrolidone, polyvinyl methyl ether, polymethoxyethyl acrylamide, polymethoxyethyl methacrylamide, polymethoxyethyl vinyl ether, polytetrahydrofurfuryl acrylate, and polytetrahydrofurfuryl methacrylate.
(In formula 1, R1 is a hydrogen atom or a methyl group, R2 is a methyl group or an ethyl group, m is an integer of 1, 2, or 3, and n is a repeating unit.)
(In formula 2, R1 is a hydrogen atom or a methyl group, and n is a repeating unit.)
(In formula 3, X and Y are each independently a hydrogen atom, an alkali metal atom, or an ammonium group, m is an integer of 0, 1, or 2, and n is a repeating unit.)
(In formula 4, R1 is a hydrogen atom or an organic group having 1 to 30 carbon atoms, and n is a repeating unit.)

### Claim at position 20

20-60. (canceled)
